<h3>認識您的 ETF 人工智能分析師</h3>
<ul>
<li>瞭解 TipRanks 的_ETF_人工智能分析師如何幫助您做出更明智的投資決策</li>
<li>探索 TipRanks 用户喜愛的 ETF，並查看 <strong>_ETF_人工智能分析師</strong> 對您關注的 ETF 所揭示的見解。</li>
</ul>
<p>IVD Medical Holding Limited（(HK:1931)）剛剛發佈了一項更新。</p>
<p>IVD Medical Holding Limited 已宣佈收購 B-Soft Co., Ltd.的重大股份，此舉使公司在 B-Soft 中持有約 12.64% 的投票權。這項價值 5 億人民幣的戰略收購涉及購買 96,525,096 股 A 股，佔 B-Soft 總髮行股本的 6.23%。此外，公司通過與供應商和一傢俬募基金的協議，獲得了額外 195,780,282 股 A 股的投票權。該交易被歸類為根據上市規則第 14 章的可披露交易，需進行報告和公告，但免於股東批准。收購需依賴監管批准及其他條件，利益相關者應謹慎行事。</p>
<p>（HK:1931）股票的最新分析師評級為持有，目標價格為 7.00 港元。要查看 IVD Medical Holding Limited 股票的完整分析師預測列表，請參見 HK:1931 股票預測頁面。</p>
<p><strong>關於 IVD Medical Holding Limited 的更多信息</strong></p>
<p><strong>平均交易量：</strong> 2,459,716</p>
<p><strong>技術情緒信號：</strong> 買入</p>
<p><strong>當前市值：</strong> 97.1 億港元</p>

創業慧康

華檢醫療

<p>IVD Medical Holding Limited 已經收購了 B-Soft Co., Ltd 的重要股份，持有約 12.64% 的投票權。此次收購的價值為人民幣 5 億元，涉及購買 96,525,096 股 A 股，並獲得額外 195,780,282 股 A 股的投票權。該交易被歸類為上市規則第 14 章下的可披露交易，需進行報告但免於股東批准。此次收購需獲得監管機構的批准</p>

<h3>Meet Your ETF AI Analyst</h3>
<div class="lb-trans"><h3>認識您的 ETF 人工智能分析師</h3>
</div><ul>
<li>Discover how TipRanks' <em>ETF</em> AI Analyst can help you make smarter investment decisions</li>
<li>Explore ETFs TipRanks' users love and see what insights the <strong><em>ETF</em> AI Analyst</strong> reveals about the ones you follow.</li>
</ul>
<div class="lb-trans"><ul>
<li>瞭解 TipRanks 的_ETF_人工智能分析師如何幫助您做出更明智的投資決策</li>
<li>探索 TipRanks 用户喜愛的 ETF，並查看 <strong>_ETF_人工智能分析師</strong> 對您關注的 ETF 所揭示的見解。</li>
</ul>
</div><p>IVD Medical Holding Limited ( (HK:1931) ) just unveiled an update.</p>
<div class="lb-trans"><p>IVD Medical Holding Limited（(HK:1931)）剛剛發佈了一項更新。</p>
</div><p>IVD Medical Holding Limited has announced its acquisition of a significant stake in B-Soft Co., Ltd, a move that positions the company to hold approximately 12.64% of the voting rights in B-Soft. This strategic acquisition, valued at RMB500 million, involves the purchase of 96,525,096 A shares, representing 6.23% of B-Soft’s total issued share capital. Additionally, the company has secured voting rights for an additional 195,780,282 A shares through agreements with the vendor and a private fund. This transaction is classified as a discloseable transaction under Chapter 14 of the Listing Rules, requiring reporting and announcement but exempt from shareholder approval. The acquisition is contingent on regulatory approvals and other conditions, and stakeholders are advised to exercise caution.</p>
<div class="lb-trans"><p>IVD Medical Holding Limited 已宣佈收購 B-Soft Co., Ltd.的重大股份，此舉使公司在 B-Soft 中持有約 12.64% 的投票權。這項價值 5 億人民幣的戰略收購涉及購買 96,525,096 股 A 股，佔 B-Soft 總髮行股本的 6.23%。此外，公司通過與供應商和一傢俬募基金的協議，獲得了額外 195,780,282 股 A 股的投票權。該交易被歸類為根據上市規則第 14 章的可披露交易，需進行報告和公告，但免於股東批准。收購需依賴監管批准及其他條件，利益相關者應謹慎行事。</p>
</div><p>The most recent analyst rating on (HK:1931) stock is a Hold with a HK$7.00 price target. To see the full list of analyst forecasts on IVD Medical Holding Limited stock, see the HK:1931 Stock Forecast page.</p>
<div class="lb-trans"><p>（HK:1931）股票的最新分析師評級為持有，目標價格為 7.00 港元。要查看 IVD Medical Holding Limited 股票的完整分析師預測列表，請參見 HK:1931 股票預測頁面。</p>
</div><p><strong>More about IVD Medical Holding Limited</strong></p>
<div class="lb-trans"><p><strong>關於 IVD Medical Holding Limited 的更多信息</strong></p>
</div><p><strong>Average Trading Volume:</strong> 2,459,716</p>
<div class="lb-trans"><p><strong>平均交易量：</strong> 2,459,716</p>
</div><p><strong>Technical Sentiment Signal:</strong> Buy</p>
<div class="lb-trans"><p><strong>技術情緒信號：</strong> 買入</p>
</div><p><strong>Current Market Cap:</strong> HK$9.71B</p>
<div class="lb-trans"><p><strong>當前市值：</strong> 97.1 億港元</p>
</div>

華檢醫療收購了創業慧康有限公司的重大股份